Becton Dickinson’s COVID-19 and Flu Combo Test Gets EUA, CE Mark

Becton Dickinson has received both FDA Emergency Use Authorization (EUA) and CE mark certification for its molecular diagnostic test for SARS-CoV-2 and influenza A and B.

The BD SARS-CoV-2/Flu assay is run on the company’s BD MAX molecular diagnostic platform and can differentiate between COVID-19 and flu infections using a single sample. The BD MAX system can analyze hundreds of samples in a 24-hour period.

The new test, which BD said can successfully detect the UK and South African coronavirus variants, provides a positive or negative result for both COVID-19 and the flu.